ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.135,26
0,42%
S&P 500
5.220,53
-0,04%
US Dollar vs BRL
5,1506
0,08%
Bitcoin
62.694,00
2,04%
Brent Oil
83,165
0,95%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. ProQR Therapeutics NV (PRQR)

  7. ProQR Therapeutics NV (PRQR) Notícias

PRQR

ProQR Therapeutics NV (PRQR)

ProQR Therapeutics NV
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:PRQR
DataHoraFonteTítuloCódigoCompanhia
09/05/202408:02Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRQRProQR Therapeutics NV
14/02/202408:08Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:PRQRProQR Therapeutics NV
14/09/202318:20Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:PRQRProQR Therapeutics NV
16/05/202308:16Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:PRQRProQR Therapeutics NV
25/04/202307:06Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:PRQRProQR Therapeutics NV
24/04/202317:31Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:PRQRProQR Therapeutics NV
29/03/202317:55Edgar (US Regulatory)Withdrawal of Registration Statement (rw)NASDAQ:PRQRProQR Therapeutics NV
29/03/202317:54Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-3)NASDAQ:PRQRProQR Therapeutics NV
29/03/202317:08Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:PRQRProQR Therapeutics NV
14/02/202312:14Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PRQRProQR Therapeutics NV
10/11/202208:35TipRanksProQR (PRQR) Gets a Buy from H.C. WainwrightNASDAQ:PRQRProQR Therapeutics NV
09/11/202217:40TipRanksAnalysts Offer Insights on Healthcare Companies: Ionis Pharmaceuticals (IONS) and ProQR (PRQR)NASDAQ:PRQRProQR Therapeutics NV
11/08/202222:15TipRanksChardan Capital downgrades ProQR (PRQR) to a HoldNASDAQ:PRQRProQR Therapeutics NV
11/08/202209:37TipRanksProQR (PRQR) was downgraded to a Hold Rating at JMP SecuritiesNASDAQ:PRQRProQR Therapeutics NV
05/08/202207:38TipRanksH.C. Wainwright Thinks ProQR’s Stock is Going to RecoverNASDAQ:PRQRProQR Therapeutics NV
04/08/202219:35TipRanksChardan Capital Reaffirms Their Buy Rating on ProQR (PRQR)NASDAQ:PRQRProQR Therapeutics NV
04/08/202218:25TipRanksJMP Securities Thinks ProQR’s Stock is Going to RecoverNASDAQ:PRQRProQR Therapeutics NV
08/05/202223:35TipRanksProQR (PRQR) Gets a Hold Rating from Stifel NicolausNASDAQ:PRQRProQR Therapeutics NV
06/05/202208:46TipRanksChardan Capital Reiterates a Buy Rating on ProQR (PRQR)NASDAQ:PRQRProQR Therapeutics NV
06/05/202201:55TipRanksJMP Securities Reiterates a Buy Rating on ProQR (PRQR)NASDAQ:PRQRProQR Therapeutics NV
14/04/202208:25TipRanksChardan Capital Remains a Buy on ProQR (PRQR)NASDAQ:PRQRProQR Therapeutics NV
14/04/202201:25TipRanksJMP Securities Reiterates Their Buy Rating on ProQR (PRQR)NASDAQ:PRQRProQR Therapeutics NV
09/02/202212:27Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:PRQRProQR Therapeutics NV
04/02/202211:13Edgar (US Regulatory)Schedule 13gNASDAQ:PRQRProQR Therapeutics NV
20/01/202202:25TipRanksJMP Securities Keeps Their Buy Rating on ProQR (PRQR)NASDAQ:PRQRProQR Therapeutics NV
16/12/202118:15TipRanksProQR (PRQR) Gets a Buy Rating from JMP SecuritiesNASDAQ:PRQRProQR Therapeutics NV
09/09/202112:20Dow Jones NewsProQR Therapeutics Shares Rise 29% After Research Deal With LillyNASDAQ:PRQRProQR Therapeutics NV
26/03/202113:33TipRanksAnalyst Lights Up Over ProQR Blindness Trial ResultsNASDAQ:PRQRProQR Therapeutics NV
21/01/202112:34TipRanks2 “Strong Buy” Penny Stocks That Could See Outsized GainsNASDAQ:PRQRProQR Therapeutics NV
06/08/202017:34Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:PRQRProQR Therapeutics NV
 Apresentando as notícias mais relevantes sobre:NASDAQ:PRQR

Seu Histórico Recente

LSE
0RV6
Siemens
TSXV
FIX
Firebird Resources
DGFX
QTUMBTC
Qtum
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados